Promethazine is known to have protective activity in relation to CCl4-induced liver necrosis-. This hepatoprotective property has been investigated with regard to the free radical scavenging and antioxidant properties of promethazine using isolated hepatocytes and m-icrosomal suspensions. CC14 is activated in both systems to free radical metabolites that bind covalently to lipid and protein, and initiate lipid peroxidation. A large number of carbonyl products is produced during CCl4-induced lipid peroxidation; promethazine strongly inhibits the production of all classes of carbonyl compounds in both microsomal suspensions and isolated hepatocytes. In contrast, promethazine is a very weak inhibitor of the covalent binding of metabolites of CC14. We conclude that promethazine acts by scavenging the trichloromethylperoxyl radical and lipid peroxyl radicals, and is a weak scavenger of the trichloromethyl radical. These data, when considered together with the hepatoprotective effects of promethazine, suggest that lipid peroxidation is of relatively more importance than covalent binding in the pathogenesis of CCl4-induced liver necrosis.
INTRODUCTION
Intoxication with CC14 leads to well-characterized fatty degeneration and centrilobular necrosis of the liver (see Slater, 1972a , for review), and the pro-oxidant effect ofthe haloalkane has been invoked to explain, at least in part, the pathogenesis of this specific injury (see Slater, 1966a Slater, , 1982 Recknagel, 1967) . The biochemical characterization of the CCl4-induced stimulation of lipid peroxidation was first studied extensively using rat liver microsomes (Slater & Sawyer, 1971a,b,c) , and has been investigated more recently using isolated intact hepatocytes (Poli et al., 1979 (Poli et al., , 1983a ). The latter model allows a more physiological but still relatively simple approach to the problem.
The phenothiazine drug promethazine is of special interest among the wide variety of antioxidants tested to investigate the role of lipid peroxidation in the pathogenesis of CCl4-induced liver cell injury. It was the first antioxidant clearly demonstrated to have hepatoprotective properties against the necrogenic action of CC14 (Rees et al., 1961) and against changes produced by CC14 in the endoplasmic reticulum in vivo (Slater & Sawyer, 1969) . This protective effect, confirmed by Reddrop et al. (1983) , has been connected with the strong inhibition shown by the drug of malonaldehyde (MDA) production stimulated by CC14 in rat liver microsomes (Slater & Sawyer, 1971 b) .
The stimulus for the present study of the antioxidant effects of promethazine on the formation of the aldehydic derivatives of lipid peroxidation is the rapidly increasing interest in the general biological involvement of this class of biochemical intermediates (see Esterbauer, 1985; Slater, 1987) . In Slater & Sawyer (1971a) after the animals had been deprived of food overnight (16 h). Microsomal incubations were carried out for 15 min at 37°C in the presence of CC14 (8.6 mM) in a defined medium (Slater & Sawyer, 1971 a) containing a NADPH-generating system; CCI4 Vol. 264 Abbreviations used: DPNH, 2,4-dinitrophenylhydrazine; HNE, 4-hydroxynon-2-enol, MDA, malonaldehyde.
was omitted from the control incubations. The gas phase was air.
Hepatocytes were prepared as previously described (Poli et al., 1981) and incubated for 60 min (when not otherwise indicated) in closed 50 ml flasks at 37°C in 3 ml of a defined balanced salt solution (Poli et al., 1979) at 5 x 106 cells/ml in the presence of CCI4, which was added to the centre well and allowed to diffuse into the closed system; the gas phase was air. Cell viability was checked before and after the incubation by Trypan Blue exclusion and by the release of lactate dehydrogenase (Poli et al., 1979) . When required, promethazine hydrochloride was added directly to the microsomal or cell suspensions at final concentrations of 10 or 100 /tM respectively.
The 02 concentration in the aqueous media used for incubations of microsomal suspensions and hepatocytes was in the range that is known to be appropriate for studies on lipid peroxidation in vitro (Lumper et al., 1968; Slater, 1972a; Noll & De Groot, 1984; De Groot & Noll, 1986) , and was similar to 02 concentrations in normal portal venous blood in situ (Kessler et al., 1984; Lemasters et al., 1986) . Preparation and extraction of the 2,4-dinitrophenylhydrazine derivatives of carbonyl-compounds
The aldehydic compounds formed during microsomal and hepatocyte incubations in the presence of CC14, with or without the addition of promethazine, were allowed to react with 2,4-dinitrophenylhydrazine (DNPH); the hydrazone derivatives were then extracted according to the procedure previously described (Esterbauer et al., 1982; Poli et al., 1985) . Quantitative determination and h.p.l.c. analysis of the individual carbonyl classes
To separate the complete mixture of dinitrophenylhydrazones into polar and non-polar classes, the aldehydic extract was separated by t.l.c. (silica gel 60, precoated 20 cm x 20 cm plates; Merck) with dichloromethane as first developer and benzene as a second developer (Esterbauer et al., 1982) . All compounds with an RF greater than or equal to that of 4-hydroxynonenal (HNE) are hydrazones of medium to low polarity and are called non-polar hydrazones from here on; compounds with lower RF values are called polar hydrazones. The non-polar hydrazones were separated by t.l.c. into individual classes corresponding to 4-hydroxyalkenals (zone I), osazones (zone II) and alkanals, alkenals and ketones (zone III).
The assignment of various bands into certain carbonyl classes was done by comparison with known standards (Esterbauer et al., 1982) . The individual fractions were scraped off the plates and eluted three times with 10 ml of methanol, the eluate being collected by centrifugation. The material remaining at the origin was adjusted to 1 ml in methanol, whereas the three non-polar fractions (hydroxyalkenals, osazones and alkanals etc.) were further purified by t.l.c. and collected as in the first step, then adjusted to 1 ml of methanol. The total carbonyl content of each fraction was estimated spectrophotometrically by recording u.v.-visible spectra and calculating the concentration from the absorbance at 365 nm using an average molar absorption coefficient of 25000 litre -mol-cm-' (Esterbauer et al., 1982) .
The individual hydrazones of each fraction were separated by h.p.l.c. with the conditions indicated in the Figure legends. Peak quantification was achieved by separating authentic standards under identical conditions.
Other analytical procedures MDA was measured by the thiobarbituric acid assay (Slater & Sawyer, 1971a) which, under these conditions, gives results corresponding closely to direct h.p.l.c. measurements of MDA (Esterbauer & Slater, 1981) . '4CCI4 covalent binding to liver microsomal proteins and to total lipid or protein of isolated hepatocytes was measured using procedures described elsewhere (Cheeseman, 1982a; Poli et al., 1983b 1989 RESULTS
Microsome suspensions
The addition of promethazine to microsomal suspensions led to a very strong reduction in the CC14-stimulated generation of both polar and non-polar aldehydes. This is illustrated in Fig. 1 for the hydroxyalkenal fraction (zone I carbonyls) separated by t.l.c. On the basis of the absorbance at 365 nm, CC14 stimulates the formation of hydroxyalkenals about 2-fold over the level found in microsomes incubated in the absence of CC14 but in the presence of NADPH. Promethazine, at a concentration of 10 /tM, completely suppressed the CCl4-stimulated production of hydroxyalkenals, as well as that due to endogenous (NADPH-stimulated) lipid peroxidation. Promethazine also totally inhibited the formation of zone II carbonyls, and partially inhibited the production of zone III carbonyls. The inhibitory effect of promethazine on zone I carbonyls is also seen when one particular hydroxyalkenal, HNE, is measured directly by h.p.l.c. (Table 1 ) and is comparable with the strong inhibition that is produced by promethazine of CC14-stimulated MDA production (Table 1; Slater & Sawyer, 1971c) .
Although promethazine shows a strong inhibition of the lipid peroxidation process triggered by CC14, this compound is a poor inhibitor of the haloalkylation of protein that occurs simultaneously with lipid peroxidation in CC14 poisoning. In fact, the same concentration of promethazine that was found to be strikingly effective as an antioxidant (10 /tM) reduces covalent binding of CC14 metabolites to microsomal protein by no more than 1O-20 %, and the extent of inhibition of covalent binding was only about 30 % in the presence of 100 ,M-promethazine (Fig. 2) .
Isolated hepatocytes
The formation of a wide range of carbonyl products of lipid peroxidation in isolated hepatocytes poisoned with CC14 has been previously demonstrated by us (Poli et al., 1985) and is confirmed here and, in addition, the effects of promethazine are shown ( Table 2 ). The stimulation by CC14 of the production of MDA and of polar and nonpolar carbonyls was effectively suppressed by the addition of promethazine to the cell incubation medium at a concentration of 100 aM (Table 2 ). This concentration was chosen on the basis of previous results achieved in the intact hepatocyte model showing a complete inhibition by this phenothiazine of CCl4-stimulated MDA production at concentrations between 50 and 100 IM (Poli et al., 1978; Poli & Gravela, 1982) . As was found with liver microsomes, the stimulation of hydroxyalkenal production by CC14 was totally prevented by promethazine as measured by the absorbance at 365 nm of the hydrazone derivatives separated by t.l.c. (Table 2 ). This strong inhibition was confirmed in the case of HNE Vol. 264 (Fig. 3) . The CCl4-induced increase in carbonyls yielding osazones with DNPH (i.e. a-dicarbonyls and 2-hydroxyaldehydes) and in the alkanals, 2-alkenals and ketones was markedly and almost completely prevented by promethazine (Table 2) . Promethazine, even at a concentration of 100 JuM, was consistently ineffective in preventing the covalent binding of CCl4 metabolites to both protein and lipid in whole hepatocytes (Table 3 ). Higher concentrations of promethazine cannot be used because of the cytotoxicity of this amphipathic material at concentrations greater than about 150 JIM (see Slater, 1972b) . DISCUSSION Promethazine was reported by Rees et al. (1961) to substantially reduce the extent of liver necrosis in rats given CC14, but to have little effect on the increased content of triacylglycerols that is another feature of this type of liver injury. The effects of promethazine in the rat in relation to CCl4-induced liver injury were further studied by Reddrop et al. (1983) who described a number of contributory mechanisms for protective action. These included a significant decrease in body temperature when promethazine and CC14 were given together to rats, a decreased rate of uptake of CCI4 into the blood and liver in the presence of promethazine, an increased respiratory rate and exhalation of CC14, and scavenging of reactive free radicals by promethazine. In addition, Reddrop et al. (1983) reported the concentrations of promethazine that occur in the liver 1-2 h after administration to rats to be in the range of 10-50,uM.
CC14 has been shown (see Slater, 1982) to damage the liver by a variety of mechanisms. One mechanism of considerable importance is the pro-oxidant action of CC14 resulting in a stimulation of lipid peroxidation (Comporti et al., 1965; Ghoshal & Recknagel, 1965; Slater, 1966b) . It is of interest to note, therefore, that promethazine inhibits this CCl4-mediated lipid peroxidation both in vivo (Jose & Slater, 1972) and in vitro (Slater & Sawyer, 1971a) at concentrations compatible with those known to occur in the whole animal after dosing (Reddrop et al., 1983) . Another contributory mechanism to the overall injury produced in the liver by CC14 is known to be covalent binding (see Reynolds & Yee, 1968) . However, promethazine, whilst protecting the liver against necrosis in vivo, has very little effect on covalent binding of CC14 to microsomes (Cheeseman, 1982a,b) . In earlier studies it was difficult to understand these different effects of promethazine on lipid peroxidation and covalent binding, since both phenomena were thought to be due to the same reactive species, the trichloromethyl radical CC13. The discovery (Packer et al., 1978) , that 'CC13 reacts very rapidly with molecular O2 to give the much more reactive CC1300 species allows the interpretation that it is this peroxyl species that initiates lipid peroxidation, whilst 'CC13 is largely responsible for covalent binding (Slater, 1982) . Subsequent studies showed that CC1300 reacts very rapidly with polyunsaturated fatty acids to initiate lipid peroxidation (Forni et al., 1983) and with promethazine (the second-order rate constants for the interactions of CC1300 with oleic, linoleic, linolenic and arachidonic acids were respectively 1.7, 3.9, 7.0 and 7.3 x 106 M-1 * s-l; the corresponding value for the interaction of CC1300 , 1980) ; the interaction of CC13 with promethazine is relatively very slow. The main effect of promethazine on CCl4-mediated damage in microsomal suspensions appears to be by scavenging CCl300-free radicals that would otherwise initiate lipid peroxidation and most probably also by scavenging lipid peroxyl radicals, since promethazine also has antioxidant effects in other lipid peroxidation systems (Slater, 1968; Cheeseman, 1982a,b) . An alternative possibility is that promethazine essentially blocks metabolic activation of CC14 to CC13 by the cytochrome P450 system, but this is ruled out for three main reasons.
Firstly, promethazine does not significantly affect covalent binding of CC14 to microsomes (Fig. 2) , a process dependent on the production of 'CCl3. Secondly, the effects of promethazine on CCl4-stimulated lipid peroxidation in microsomes occur at a much lower concentration than that causing inhibitory effects on cytochrome P,50-linked drug metabolism (Fig. 2) . Thirdly, promethazine (50 lM) has no significant effect on the formation of the spin adduct of 'CC13 with phenyl-tbutyl nitrone, as demonstrated by e.s.r. spectroscopy (results not shown).
Another possible mechanisms for promethazine action is related to the inhibitory action of phenothiazines on calmodulin and hence on Ca2" movements (Uzanov et al., 1974; Norman et al., 1979) . Although this is probably not of significance in the microsomal studies, it is a factor to consider in isolated hepatocytes where disturbances of Ca2" transport have been proposed to be of significance to cell injury (Moore et al., 1976; Schanne et al., 1979) , but this still remains controversial (see Smith & Sandy, 1985) . A remote possibility that promethazine exerts its effects on the production ofaldehydes by combining directly with them can be unequivocally ruled out for two reasons. Firstly, promethazine inhibits lipid peroxidation at very low final concentrations (EC50 0.6 ftM; Slater & Sawyer, 1971c ; see also Fig. 2) , much lower than the concentration of aldehydes produced in its absence. Secondly, direct addition of promethazine to 4-hydroxy-alkenals has no effect on the u.v. absorption spectra, or on t.l.c. separations.
Lipid peroxidation is an important feature of CC14-mediated damage to microsomal suspensions, to isolated hepatocytes and to liver in vivo. Important products of lipid peroxidation are the 4-hydroxy-alkenals; these have many important biological properties (see Esterbauer, 1985) . It has been proposed that the formation of such aldehydes in the endoplasmic reticulum, followed by diffusion into the cytosol and extracellular space, permits a widespread diffusion of damaging events (Slater, 1976) . In consequence, any attempt to attenuate the damaging effects of CC14 and similar compounds should be aimed at decreasing the production of these biologically reactive carbonyls.
In this study we have shown that promethazine has a very strong inhibitory action on the production of carbonyl products of lipid peroxidation in general and of 4-hydroxyalkenals in particular, both in microsomes and in isolated hepatocytes. This is the first study to show that a protective antioxidant decreases the production of cytotoxic aldehydes in liver cells exposed to a hepatotoxic agent (CCI4). Evaluation of the results obtained suggests that this effect of promethazine is via a scavenging action on the reactive peroxyl intermediate CC1300O that can initiate lipid peroxidation followed by breakdown of lipid hydroperoxides to carbonyls, as well as by scavenging lipoperoxyl radicals that carry the chain reaction. In both microsomes and isolated hepatocytes there was no significant effect of promethazine on covalent binding, which suggests that this aspect of CC14 metabolism is of relatively lesser significance in the production of necrosis in vivo than is lipid peroxidation.
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